SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-17-000055
Filing Date
2017-05-09
Accepted
2017-05-09 17:23:04
Documents
48
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-3311710q.htm 10-Q 767155
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 14050
3 EXHIBIT 31.1 lgnd_33117exhibit311.htm EX-31.1 16488
4 EXHIBIT 31.2 lgnd_33117exhibit312.htm EX-31.2 16385
5 EXHIBIT 32.1 lgnd_33117exhibit321.htm EX-32.1 15608
  Complete submission text file 0000886163-17-000055.txt   4539052

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20170331.xml EX-101.INS 969110
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20170331.xsd EX-101.SCH 28452
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20170331_cal.xml EX-101.CAL 72476
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20170331_def.xml EX-101.DEF 145355
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20170331_lab.xml EX-101.LAB 499779
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20170331_pre.xml EX-101.PRE 272544
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 17827588
SIC: 2834 Pharmaceutical Preparations